The distribution between different hepatitis C virus (HCV) genotypes has potentially important clinical and epidemiological implication. With this view, sera samples from 74 chronically HCV infected patients were characterized by Murex HCV Serotyping 1-6 assay during the course of this investigation. Serotyping assay utilized type-specific antibodies for the NS4 region of HCV genome. Out of the 74 tested serum samples, serotype-specific antibodies were detected in 61 (82.4%) serum samples. Thirteen (17.5%) out of total 74 serum samples were found untypable by the present typing systems. Out of the 61 typable patients, eight (13.1%) were of type-1, two (3.2%) were of type-2, forty four (72.1%) were of type-3, one (1.6%) each was of type 5 and type 6 and five (8.1%) were of dual infections (one patient had types 2,3 and two each had types 1,3 and 3,6 dual infections). Out of the total 13 untypable serum samples, 6 were PCR positive and two were PCR negative, where as PCR was not done for the rest of five patients due to insufficient serum samples. More than 88% (55/62) of the HCV-RNA positive samples were typed by this method. In conclusion, i) In Pakistan the most prevalent HCV serotype was found to be type 3, accounting 72.1 % of the total cases, ii) serotype 4 was totally absent in this study, iii) serotyping assay have the advantages of low cost, rapid test procedure and requirement of minimal equipments iv) the serotyping assay lacks the possibility of HCV subtyping as HCV subtyping can only be achieved by genotyping assays.